Treatment Response and 5-Year Distant Metastasis-Free Survival Outcome in Breast Cancer Patients after the Use of MammaPrint and BluePrint to Guide Preoperative Systemic Treatment Decisions
EUROPEAN JOURNAL OF CANCER(2022)
Key words
Breast cancer,MammaPrint,BluePrint,Core needle biopsy,Neoadjuvant treatment,Reclassification,Follow-up,Genomic profiling
AI Read Science
Must-Reading Tree
Example

Generate MRT to find the research sequence of this paper
Chat Paper
Summary is being generated by the instructions you defined